Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform

Wang, 2021, Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm, Matter, 5, 336, 10.1016/j.matt.2021.09.022 Osminkina, 2022, Antiviral adsorption activity of porous silicon nanoparticles against different pathogenic human viruses, Bioact. Mater., 7, 39, 10.1016/j.bioactmat.2021.06.001 Maslanka Figueroa, 2021, Biomedical nanoparticle design: What we can learn from viruses, J. Control. Release, 329, 552, 10.1016/j.jconrel.2020.09.045 Lu, 2021, Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands, Nat. Commun., 12, 6802, 10.1038/s41467-021-27096-9 Rahardjo, 2021, Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series, J. Med. Case Reports, 15, 564, 10.1186/s13256-021-03059-y Brouwer, 2020, Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability, Science, 369, 643, 10.1126/science.abc5902 Yamaguchi, 2021, ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury, Nat. Commun., 12, 6791, 10.1038/s41467-021-27097-8 Mueller, 2021, Clinical characterization of respiratory large droplet production during common airway procedures using high-speed imaging, Sci. Rep., 11, 10627, 10.1038/s41598-021-89760-w Chen, 2021, SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19, N. Engl. J. Med., 384, 229, 10.1056/NEJMoa2029849